Exosome Diagnostics Selects Promega Corp. for cGMP Clinical Sample Concentrator Kit

NEW YORK — Exosome Diagnostics today announced it has reached an agreement with Promega Corporation to be the exclusive supplier of its Urine Clinical Sample Concentrator Kit. Promega will manufacture the Clinical Sample Concentrator Kit under current good manufacturing practices (cGMP) in their Madison, Wisconsin manufacturing facility. The kit incorporates Exosome's proprietary method for concentration [...]

torchV10 Brings the Next Generation of Molecule Design to the Desktop

Welwyn Garden City, UK –– Cresset, innovative provider of software and services, announces the release of torchV10, a complete desktop molecular design and 3D SAR tool for medicinal chemists. torchV10 uses molecular fields to show the binding patterns of your compounds. This protein’s eye view gives clear insights into the causes of biological activity. Working [...]

PerkinElmer Announces Financial Results for the Third Quarter of 2012

WALTHAM, Mass.-- PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and the environment, today reported financial results for the third quarter ended September 30, 2012. The Company reported GAAP earnings per share from continuing operations of $0.25, compared to $0.25 in the third quarter of 2011. Revenue [...]

Agilent Technologies’ and PREMIER Biosoft’s Platforms Work Together to Advance Lipidomics Research

Agilent Technologies Inc. (NYSE: A) and PREMIER Biosoft today announced that they will each support the combined use of their respective technologies to help clinical researchers advance lipidomics research. By integrating complementary technologies, researchers can seamlessly generate and process data, then map complex lipidomic networks to learn more about lipid metabolism associated with disease. The [...]

Corning Announces Cash Tender Offer for up to $75 Million Aggregate Principal Amount of its Outstanding Debt Securities and Redemption of Two Series of Outstanding Debt Securities

CORNING, N.Y., – Corning Incorporated (NYSE:GLW) announced today that it has commenced a cash tender offer for up to $75 million aggregate principal amount of specified series of its outstanding debt. The terms and conditions of the tender offer are set forth in an Offer to Purchase dated today. The Company will also redeem $174 [...]

Corning Prices $250 Million of Senior Unsecured Notes

CORNING, N.Y., – Corning Incorporated (NYSE:GLW) announced today that it has priced $250 million aggregate principal amount of senior unsecured notes at a coupon of 1.45%. The notes will mature on November 15, 2017. Subject to customary closing conditions, the transaction is expected to close on October 31, 2012. A portion of the net proceeds [...]

Perfect Prescription for Tablet Coating Tests!

Middleboro, MA – Brookfield Engineering Laboratories offers the TA-TCA Tablet Coating Adhesion Fixture for their CT3 Tester. The Tablet Coating Adhesion Fixture is designed to measure how well the coating adheres to the surface of a tablet. The fixture compresses the tablet firmly between the double-sided sticky tape on both probes and attempts to pull [...]

Transmitter Displays and Controls pH and ORP Values for Process Monitoring

Garden Grove, California -- Sensorex’s TX-3000 pH/mV Transmitter monitors changes in process fluids, displaying pH or oxidation reduction potential (ORP, measured in mV), and temperature for more accurate control in water, chemical, electronics, food production, environmental and wastewater applications. The line-powered TX-3000 can be user programmed on-site to measure either pH or ORP (Redox). Its [...]

Bulldog Bio Given Exclusive Right to Sell Novel Cloning Technology from Australia

GeneWorks Pty Ltd (Australia) introduces the Acquire PCR Cloning*. Acquire will be sold exclusively through Bulldog Bio in the USA. Ella Fontaine, V.P. of Communication at Bulldog Bio relates “The technology incorporated into the Acquire PCR Cloning Kit will provide our customers with the potential for extraordinary results from both A-tailed and blunt-ended PCR products, [...]

Mediomics LLC Receives Phase II SBIR Contract: Award $997,251 to Develop New In-Process Analyzer for Biologicas

Mediomics, LLC has been awarded a $997,251 Phase II SBIR contract (HHSN261201200081C) from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services. This project builds on successful Phase I research, and aims to develop a fully automated in-process analyzer to monitor the titer and quality of recombinant biologics. Using Mediomics’ [...]

Access IBO on Knowledge Center